Chopra, Slaughter: FTC approval of Pfizer/Mylan may invite collusion
Both Democratic members of the Federal Trade Commission have warned that the conditional approval of Pfizer’s sale of its Upjohn division to Mylan may make it easier for companies in the pharmaceutical industry to coordinate prices.
Subscribe to Global Competition Review
Subscribe and start reading now
Global Competition Review (GCR) is the complete source of news and analysis for competition practitioners. It keeps you up to speed with the issues and trends that matter, giving you the detail, and depth, you need to operate successfully.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10